Pharmaceuticals, Biotechnology and Life Sciences
BASEL, Switzerland, April 13, 2021 (GLOBE NEWSWIRE) — VectivBio Holding AG, (“Vectiv” or “VectivBio”) (Nasdaq: VECT), a clinical stage biopharmaceutical…
BASEL, Switzerland, April 13, 2021 (GLOBE NEWSWIRE) — In a press release issued under the same headline earlier today by…
PARIS and CAMBRIDGE, Mass., April 13, 2021 (GLOBE NEWSWIRE) — BIOPHYTIS SA (NasdaqCM: BPTS, Euronext Growth Paris: ALBPS), a clinical-stage biotechnology…
Company Announcement COPENHAGEN, Denmark; April 13, 2021 – Genmab A/S (Nasdaq: GMAB) In accordance with Article 19 of Regulation No.…
Company Announcement COPENHAGEN, Denmark; April 13, 2021 – Genmab A/S (Nasdaq: GMAB) Following Genmab A/S’ Annual General Meeting held on…
SAN DIEGO, April 13, 2021 (GLOBE NEWSWIRE) — Adamis Pharmaceuticals Corporation (NASDAQ: ADMP), a biopharmaceutical company developing and commercializing specialty…
LEIDEN, Netherlands & CAMBRIDGE, Mass., April 13, 2021 (GLOBE NEWSWIRE) — ProQR Therapeutics N.V. (Nasdaq:PRQR), a company dedicated to changing lives…
Maryland-based physicians can quickly deploy remote care options for patients with PRA’s digital health technologyRALEIGH, N.C. and BALTIMORE, April 13,…
UPPSALA, SWEDEN – The shareholders of LIDDS AB (publ), corp. ID no. 556580-2856, are invited to the Annual General Meeting…
On track to initiate Phase 1 trials for four wholly owned drug candidates in 2021 Expanded Sanofi collaboration resulting in…